G1 Therapeutics, Inc. (GTHX)
NASDAQ: GTHX · IEX Real-Time Price · USD
3.990
-0.200 (-4.77%)
At close: Apr 24, 2024, 4:00 PM
4.000
+0.010 (0.25%)
Pre-market: Apr 25, 2024, 8:00 AM EDT
G1 Therapeutics Market Cap
G1 Therapeutics has a market cap or net worth of $208.28 million as of April 25, 2024. Its market cap has increased by 44.04% in one year.
Market Cap
208.28M
Enterprise Value
181.77M
1-Year Change
44.04%
Ranking
Category
Stock Price
$3.99
Market Cap Chart
Since May 17, 2017, G1 Therapeutics's market cap has decreased from $400.00M to $208.28M, a decrease of -47.93%. That is a compound annual growth rate of -8.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 208.30M | -4.76% |
Apr 23, 2024 | 218.70M | 2.20% |
Apr 22, 2024 | 214.00M | -0.23% |
Apr 19, 2024 | 214.50M | -1.47% |
Apr 18, 2024 | 217.70M | -2.55% |
Apr 17, 2024 | 223.40M | 4.88% |
Apr 16, 2024 | 213.00M | -5.33% |
Apr 15, 2024 | 225.00M | -5.26% |
Apr 12, 2024 | 237.50M | -2.78% |
Apr 11, 2024 | 244.30M | 0.66% |
Apr 10, 2024 | 242.70M | -4.71% |
Apr 9, 2024 | 254.70M | 2.29% |
Apr 8, 2024 | 249.00M | -0.20% |
Apr 5, 2024 | 249.50M | 4.83% |
Apr 4, 2024 | 238.00M | -3.41% |
Apr 3, 2024 | 246.40M | 2.62% |
Apr 2, 2024 | 240.10M | 1.09% |
Apr 1, 2024 | 237.50M | 5.32% |
Mar 28, 2024 | 225.50M | -3.34% |
Mar 27, 2024 | 233.30M | 4.20% |
Mar 26, 2024 | 223.90M | 3.61% |
Mar 25, 2024 | 216.10M | 3.50% |
Mar 22, 2024 | 208.80M | 8.13% |
Mar 21, 2024 | 193.10M | 7.22% |
Mar 20, 2024 | 180.10M | 5.20% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AVITA Medical | 221.98M |
Boundless Bio | 221.28M |
Lineage Cell Therapeutics | 216.81M |
Accuray | 215.20M |
Merrimack Pharmaceuticals | 214.49M |
Actinium Pharmaceuticals | 213.13M |
Senseonics Holdings | 212.21M |
Design Therapeutics | 211.69M |